Skip to main content

#151183

Anti-CyclinA1 [XLA1-1]

Cat. #151183

Anti-CyclinA1 [XLA1-1]

Cat. #: 151183

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Cyclin A1

Class: Monoclonal

Application: WB

Reactivity: Xenopus laevis

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CyclinA1 [XLA1-1]
  • Alternate name: CCNA1; Cyclin A1; Testicular Tissue Protein Li 34; CT146
  • Research fields: Cancer;Cell biology;Genetics
  • Clone: XLA1-1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Xenopus laevis
  • Host: Mouse
  • Application: WB
  • Description: This antibody detects Xenopus Cyclin A in western blots.
  • Immunogen: Xenopus laevis cyclin A
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Cyclin A1
  • Target background: Cyclins bind to and regulate the activity of the Cyclin Dependent Protein Kinases (CDKs). Cyclin A1 is the embryonic cyclin that is present in Xenopus laevis eggs and can form complexes with CDK1 and CDK2.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Kobayashi et al. 1994. J Biol Chem. 269(46):29153-60. PMID: 7961881.
  • Cyclin A and cyclin B dissociate from p34cdc2 with half-times of 4 and 15 h, respectively, regardless of the phase of the cell cycle.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.